Page 2 - Base Genomics News Today

/PRNewswire/ -- The "Epigenetics Global Market Report 2022" report has been added to ResearchAndMarkets.coms offering. The global epigenetics market is...

Dublin, Nov. 22, 2022 (GLOBE NEWSWIRE) -- The "Epigenetics Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.The...

Exact Sciences demonstrated exceptional financial discipline during Q3, delivering robust growth with lower operating expenditure. See why I rate EXAS a Buy.

Within liquid biopsy, methylation has become a key area of interest due to its role in altering gene expression and its ability to provide...

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Replay has developed technology platforms to help jumpstart emerging gene and cell therapies.

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

         Replay Launches with $55 Million Seed to Reprogram Biology by Writing and Delivering Big DNA KKR and OMX Ventures lead $55 million seed funding...

SVB Leerink has decided to maintain its Outperform rating of Exact Sciences (NASDAQ:EXAS) and lower its price target from $130.00 to $95.00. Share...

/PRNewswire/ -- Oxford Science Enterprises, the Science Business Builder and preferred intellectual property partner of the University of Oxford, today...